Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Americans Now Favor Gold Over Stocks as an Investment Vehicle]( [See why investors are so impressed by this overlooked gold investment strategy.]( --------------------------------------------------------------- January 23, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Bezos and Gates Invest in Search for Tech's Best-Kept Secret]( who've made their fortunes in tech, are quietly investing in essential yet rare elements known as "The Seeds of Technology". Learn more about this massive rare earth treasure hunt and the very elements making emerging technologies possible. [Investor Alert: Discover a company flying-under-the-radar at the forefront of this megatrend.]( --------------------------------------------------------------- [Alpine Immune Sciences]( Ticker: [ALPN]( Recent Price: $20.10 Average Analyst Price Target: $30.25 (46.31%) Market Cap: $1.15B Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Options Exercised and fully kept 1,234,636 $15,729,263 2 Days Ago Director, >10% Owner Informative Buy Options Exercised and fully kept 1,234,636 $15,729,263 2 Days Ago Recent Analyst Action: Gregory Renza, analyst at RBC Capital, reiterates coverage on [Alpine Immune Sciences (ALPN)]( in the Healthcare sector with a Buy rating and a price target of $29 (2 weeks ago). Here are 3rd party ratings for [ALPN](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 35% (87 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Richest investors clearly worried about something big]( Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5.) [Click for full story.]( --------------------------------------------------------------- [ChargePoint Holdings]( Ticker: [CHPT]( Recent Price: $2.10 Average Analyst Price Target: $2.98 (54.29%) Market Cap: $819.33M Role Transaction Description No. of Shares Amount Date Director Informative Buy Options Exercised and fully kept 348,810 $265,096 2 Days Ago Recent Analyst Action: Chris Dendrinos, analyst at RBC Capital, reiterates coverage on [ChargePoint Holdings (CHPT)]( in the Consumer Cyclical sector with a Buy rating and a price target of $3.5 (1 week ago). Here are 3rd party ratings for [CHPT](: - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 37% (157 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [H.B. Fuller Company]( Ticker: [FUL]( Recent Price: $78.42 Average Analyst Price Target: $87.60 (11.71%) Market Cap: $4.20B Role Transaction Description No. of Shares Amount Date Director Informative Buy Options Exercised and fully kept 1,343 $103,089 2 Days Ago Recent Analyst Action: Ghansham Panjabi, analyst at Robert W. Baird, reiterates coverage on [H.B. Fuller Company (FUL)]( in the Basic Materials sector with a Hold rating and a price target of $80 (4 days ago). Here are 3rd party ratings for [FUL](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 24% (191 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [America's Cash Bubble Set to Burst on January 31, 2024]( the first time I’ve ever heard of… we know the exact day (and time) a bubble is going to burst. This is insane and something we only have access to because of Jason’s findings (that he’s sharing with his ultra-elite clients). To find out what the cash bubble is and why you’re vulnerable to it without even realizing... [Watch His Free Video Here]( --------------------------------------------------------------- [FB Financial]( Ticker: [FBK]( Recent Price: $38.62 Average Analyst Price Target: $39.30 (4.22%) Market Cap: $1.80B Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 2,000 $71,000 2 Days Ago Recent Analyst Action: Matt Olney, analyst at Stephens, reiterates coverage on [FB Financial (FBK)]( in the Financial sector with a Hold rating and a price target of $41 (6 days ago). Here are 3rd party ratings for [FBK](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 29% (74 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Lithium Americas (Argentina) Corp.]( Ticker: [LAAC]( Recent Price: $4.68 Average Analyst Price Target: $7.60 (62.57%) Market Cap: $721.49M Role Transaction Description No. of Shares Amount Date Non-Executive, Director Informative Buy Buy 5,000 C$41,600 2 Days Ago Recent Analyst Action: Joel Jackson, analyst at BMO Capital, reiterates coverage on [Lithium Americas (Argentina) Corp. (LAAC)]( in the Basic Materials sector with a Hold rating and a price target of $5.19 (2 months ago). Here are 3rd party ratings for [LAAC](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Sell, Bottom 37% (157 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Gold Could Be Heading for Record Highs - But How to Play It?]( to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. [See this little-known way to play in the rising gold market.]( --------------------------------------------------------------- [Gold Royalty]( Ticker: [GROY]( Recent Price: $1.40 Average Analyst Price Target: $3.38 (162.14%) Market Cap: $204.41M Role Transaction Description No. of Shares Amount Date Shareholder, >10% Owner Informative Buy Buy 100,000 $139,190 4 Days Ago Recent Analyst Action: Rene Cartier, analyst at BMO Capital, reiterates coverage on [Gold Royalty (GROY)]( in the Basic Materials sector with a Hold rating and a price target of $3 (1 month ago). Here are 3rd party ratings for [GROY](: - TipRanks.com: Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Bottom 16% (211 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Vivani Medical]( Ticker: [VANI]( Recent Price: $1.06 Average Analyst Price Target: $4.00 (277.39%) Market Cap: $51.54M Role Transaction Description No. of Shares Amount Date Director, >10% Owner Informative Buy Non Open Market Buy 7,620 $7,696 2 Days Ago Director, >10% Owner Informative Buy Non Open Market Buy 1,076 $1,087 5 Days Ago Recent Analyst Action: Naz Rahman, analyst at Maxim Group, reiterates coverage on [Vivani Medical (VANI)]( in the Healthcare sector with a Buy rating and a price target of $4 (2 months ago). Here are 3rd party ratings for [VANI](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Rare Earth Elements: The Workhorse of The Tech Revolution]( re the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are. [Read this free investor report to reveal who could benefit in 2024.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software